Isaac McGraw, Bettina <br/><br/>
Recurrent urinary tract infections and low secretory IgA following CD19-directed CAR T-cell therapy for relapsed acute lymphoblastic leukemia.  [electronic resource] 

 -  Pediatric blood & cancer  01 2018 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1545-5017 
<br/><br/><label>Standard No.: </label>10.1002/pbc.26739  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, CD19--analysis<br/>Antimetabolites, Antineoplastic--therapeutic use<br/>B-Lymphocytes--immunology<br/>Bacteriuria<br/>Child<br/>Clofarabine--therapeutic use<br/>Cytarabine--therapeutic use<br/>Escherichia coli--immunology<br/>Escherichia coli Infections--immunology<br/>Female<br/>Humans<br/>Immunoglobulin A, Secretory--blood<br/>Immunoglobulin G--blood<br/>Immunoglobulin M--blood<br/>Immunotherapy, Adoptive--adverse effects<br/>Lymphocyte Count<br/>Neoplasm Recurrence, Local--drug therapy<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Proteus Infections--immunology<br/>Proteus mirabilis--immunology<br/>Urinary Tract Infections--immunology